SPOTLIGHT -
Topline results from Ersa Phase 2a trial revealed by Tarsus
Thyroid eye disease: The masquerading eye disorder— a guide to accurate diagnosis and collaborative care
This week in optometry: December 4-December 8
Advances in treatment for geographic atrophy
Rapid progress: An update on corneal endothelial cell therapy
EyePoint Pharmaceuticals unveils favorable topline results from phase 2 DAVIO 2 trial evaluating EYP-1901 in wet AMD